-
Review
January 5, 2023
- Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
- Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, et al.
- Clin Mol Hepatol. 2023;29(2):197-205.
Review
January 5, 2023
Review
December 22, 2022
Review
December 28, 2022
Review
January 30, 2023
Review
March 20, 2023
Review
March 10, 2023
Review
January 19, 2023
Review
January 30, 2023
Review
February 1, 2023
Review
February 1, 2023
Original Article
November 21, 2022
Original Article
January 4, 2023
Original Article
February 1, 2023
Original Article
February 20, 2023
Original Article
January 5, 2023
Original Article
March 6, 2023
This archive contains links to the full-text of all issues of Clin Mol Hepatol.
![]() |
First decision
09 Days
Publication after acceptance
07 Days
*Last 12 months
Viewed By 4154 |
Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease |
Viewed By 3564 |
Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection |
Viewed By 2827 |
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis |
Viewed By 2782 |
Recent updates on the management of autoimmune hepatitis |
Viewed By 2705 |
Identification of high-risk subjects in nonalcoholic fatty liver disease |
Cited By 99 |
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease |
Cited By 42 |
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis |
Cited By 42 |
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple? |
Cited By 40 |
Obesity and the risk of primary liver cancer: A systematic review and meta-analysis |
Cited By 38 |
The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future |